Suven Life Sciences Ltd 530239.BO
₹342.90 ₹19.05 (5.88%) 1D
Last Updated: Aug 14, 12:00 AM·BSE
Pricing for IN stocks is delayed by 24 hours
530239.BO Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Suven Life Sciences Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Suven Life Sciences Ltd. Stock Analysis 530239.BO
India Health Care Small Cap Suven Life Sciences Ltd. engages on discovering, developing, and commercializing novel pharmaceutical products which are used in classic therapies. The firm's lead clinical-stage assets include Masupirdine (Pure 5-HT 6 receptor antagonist), Samelisant (Histamine 3 receptor inverse agonist) and Ropanicant (a4b2 antagonist). Masupirdine is an ongoing phase III study for agitation and aggression in Alzheimer's type dementias in North America and Europe. Samelisant is a study on the treatment of excessive daytime sleepiness (EDS) in adult narcolepsy patients with and without cataplexy. Ropanicant is an ongoing screening for Phase II open label study for moderate to severe major depressive disorder in United States. Its other clinical-stage assets include Usmarapride (5-HT4 receptor agonist), SUVN-I6107 (True muscarinic M1 positive allosteric modulator) and SUVN-D1044 (5-HT4 receptor agonist).
Suven Life Sciences Ltd (530239.BO) Chart
Financial Metrics & Statements of Suven Life Sciences Ltd (530239.BO)
FAQ's for Suven Life Sciences Ltd (530239.BO)
- As of August 2026, Suven Life Sciences Ltd 530239.BO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Suven Life Sciences Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Suven Life Sciences Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Suven Life Sciences Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Suven Life Sciences Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Suven Life Sciences Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Suven Life Sciences Ltd (530239.BO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
